FDA Inspection 1074349 — Intas Pharmaceuticals Limited
The FDA completed an inspection of Intas Pharmaceuticals Limited on December 14, 2018 in Ahmedabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 14, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ahmedabad (India)